Paul Majkowski
Albertson, NY

Paul Majkowski was elected to the Lymphoma Research Foundation’s Board of Directors in 2025, following close to two decades in various volunteer roles with the Foundation. Paul began his service with the Foundation as its New York City Chapter President, has served as a Foundation Ambassador, and received the Foundation’s Distinguished Service Award in 2016. He has also served the lymphoma community as an FDA Patient Representative, sitting on several Oncologic Drug Advisory Committee panels. Paul is a partner in the Complex Torts & Product Liability group of Rivkin Radler LLP, where he focuses on complex mass toxic tort litigation. Paul was diagnosed with Diffuse Large B-Cell Lymphoma in 1996, and in mid-2016, passed the milestone of having lived longer as a lymphoma survivor than prior to being diagnosed.